Page last updated: 2024-10-28

hexamethonium and Paralysis

hexamethonium has been researched along with Paralysis in 2 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fruhwald, S1
Herk, E1
Hammer, HF1
Holzer, P1
Metzler, H1
Jung, R1
Katona, PG1

Other Studies

2 other studies available for hexamethonium and Paralysis

ArticleYear
Differential reversal of drug-induced small bowel paralysis by cerulein and neostigmine.
    Intensive care medicine, 2004, Volume: 30, Issue:7

    Topics: Adjuvants, Anesthesia; Adrenergic Agonists; Animals; Atropine; Ceruletide; Dose-Response Relationshi

2004
Cardiovascular and respiratory responses to slow ramp carotid sinus pressures in the dog.
    Journal of applied physiology (Bethesda, Md. : 1985), 1990, Volume: 68, Issue:4

    Topics: Animals; Blood Pressure; Cardiovascular Physiological Phenomena; Carotid Arteries; Carotid Sinus; Do

1990
chemdatabank.com